Key result
Propofol significantly mitigated cognitive deficits and long-term potentiation impairments in aged rats with postoperative cognitive dysfunction compared to other anesthetics (p < 0.001).
Why the study?
Whether propofol exerts neuroprotective effects in postoperative cognitive dysfunction by regulating the renin-angiotensin system and mitochondria-associated endoplasmic reticulum membranes was unknown.
Does propofol prevent postoperative cognitive dysfunction and neurodegeneration in aged rats undergoing splenectomy compared to other anesthetics?
Does propofol prevent postoperative cognitive dysfunction and neurodegeneration in aged rats undergoing splenectomy compared to other anesthetics?
p-value: p=<0.001
In a rat model of postoperative cognitive dysfunction, propofol provided superior neuroprotection compared to other anesthetics by regulating the renin-angiotensin system and preserving mitochondria-associated endoplasmic reticulum membranes.
May inform neuroprotective RAS targeting in cerebrovascular disease; leaves open MAMs' mechanistic role in neurodegeneration.
The brain renin-angiotensin system (RAS) exhibits a dual role in neurodegeneration and cognitive function, the angiotensin-converting enzyme (ACE)/Ang II/angiotensin type 1 receptor (AT1R) pathway induces nerve injury, while the ACE2/Ang (1–7)/Mas receptor (MasR) pathway exerts protective effects in cerebrovascular disease. Mitochondria-associated endoplasmic reticulum membranes (MAMs)-key regulators of calcium homeostasis and mitochondrial function—are also implicated in neurodegeneration, and previous studies suggest Ang II may reduce MAM levels. Moreover, previous study indicated that Ang II could decrease the level of MAMs. However, whether propofol exerts neuroprotective effects by regulating the RAS and MAMs remains unknown. In this study, we found that the effects of propofol on cognitive function and RAS were opposite to that of other anesthetic drugs, including isoflurane, sevoflurane, chloral hydrate, pentobarbital sodium on cognitive function and RAS in the postoperative cognitive dysfunction (POCD) rats. Propofol treatment maintained the balance between ACE/Ang II/AT1 and ACE2/Ang(1–7) and improved cognitive function. In vitro, propofol inhibited Ang II-induced apoptosis, the increase in excitatory postsynaptic current (EPSC), and the downregulation of synaptophysin and PSD95. Moreover, we found the RAS was closely associated with MAMs, and propofol inhibited the Ang II-induced reduction in MAMs, increase in calcium uptake, and changes in mitochondrial reactive oxygen species (mitoROS) and mitochondrial ATP levels. Collectively, this study aimed to investigate the neuroprotective role of propofol in POCD by regulating the RAS and MAMs.
No takes yet. Share an insight, caveat, or question.
Ding et al. (2025) studied Postoperative cognitive dysfunction (n=36). Propofol vs. Isoflurane, sevoflurane, chloral hydrate, pentobarbital sodium, and control was evaluated on Cognitive performance (Morris water maze test) (p=<0.001). Propofol significantly mitigated cognitive deficits and long-term potentiation impairments in aged rats with postoperative cognitive dysfunction compared to other anesthetics (p < 0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: